Nara, Japan

Toshiharu Hashizume

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Hagihara Farm Production Institute Co., Ltd., Kinki University, Mie University. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiharu Hashizume. Retrieved from https://idiyas.com/inventor/toshiharu-hashizume

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Toshiharu Hashizume: Innovator in Cancer Research

Introduction

Toshiharu Hashizume is a notable inventor based in Nara, Japan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 3 patents, his work focuses on developing compositions that inhibit cancer cell growth.

Latest Patents

One of his latest patents is titled "NOVEL COMPOUND DERIVED FROM WATERMELON, AND COMPOSITION USING SAME." This invention addresses the challenge of utilizing phytol, a compound found in watermelon sprouts known for its cancer cell growth inhibiting effects. Hashizume's composition comprises various compounds that demonstrate a higher efficacy in inhibiting cancer cell growth compared to phytol alone.

Career Highlights

Throughout his career, Toshiharu Hashizume has worked with reputable organizations, including Hagihara Farm Production Institute Co., Ltd. and Kinki University. His research has been instrumental in advancing the understanding of cancer treatment options.

Collaborations

He has collaborated with notable colleagues such as Tomohiro Itoh and Satoru Hirabayashi, contributing to a rich exchange of ideas and research in the field.

Conclusion

Toshiharu Hashizume's innovative work in cancer research highlights the importance of developing effective treatments. His contributions continue to inspire advancements in medical science and offer hope for improved cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…